Opportunity Radar

← Back to search

Grant forecast

NIAMS Clinical Trial Implementation Cooperative Agreement

View on Grants.gov ↗ Sign in to save

Type
Grant forecast
Notice type
CA
Agency
National Institutes of Health
Sub-agency
HHS-NIH11
Solicitation #
PAR-28-031
Posted
Jun 10, 2026
Response due
Jul 2, 2027
CFDA / Assistance listing
93.846
Award floor
$250,000
Contact
National Institute of Arthritis and Musculoskeletal and Skin Diseases · NIAMS_NOFOs@mail.nih.gov · Please contact via e-mail.
Source
Grants.gov

Description

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for the Clinical Trial Cooperative Agreement Program within the mission areas of the institute. This Notice of Funding Opportunity (NOFO) solicits cooperative agreement applications for implementation of investigator-initiated, single or multi-site, interventional clinical trials (all trial phases). Investigators who have completed all necessary preparation (e.g., the trial design, protocol synopsis, data analysis plan, etc.) through other means may apply for a NIAMS Cooperative Agreement Clinical Trial. The first phase is designed to allow the investigators to prepare the final aspects needed to start the trial, (e.g., establishing the single IRB (sIRB), contracts and reliance agreements with sites, hiring of staff, etc.). Transition to the second phase to begin the trial is dependent upon completion of the phase 1 milestones proposed by the investigator and approved by NIAMS. Phase 1 projects that meet their milestones will be administratively considered by NIAMS and prioritized for transition to the second phase. NIAMS expects trials to be hypothesis-driven and have the potential for high clinical impact within the research mission of NIAMS.

Similar open opportunities